Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

被引：0
|
作者：
Gaziev, Javid [1 ]
De Angelis, Gioia [1 ]
Isgro, Antonella [1 ]
Sodani, Pietro [1 ]
Marziali, Marco [1 ]
Paciaroni, Katia [1 ]
Andreani, Marco [1 ]
Testi, Manuela [1 ]
Gallucci, Cristiano [1 ]
Alfieri, Cecilia [1 ]
Ribersani, Michela [1 ]
Troiano, Maria [1 ]
Morrone, Aldo [1 ]
Lucarelli, Guido [1 ]
机构：
[1] Policlin Vergata, Int Ctr Transplantat Thalassemia & Sickle Cell An, Mediterranean Inst Hematol, Rome, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PROPHYLACTIC DISTAL SPLENORENAL SHUNT FOR CHILDS CLASS-A AND CLASS-B PATIENTS AT HIGH-RISK OF BLEEDING
    NAGASUE, N
    OGAWA, Y
    YUKAYA, H
    SASAKI, Y
    TAMADA, R
    CHANG, Y
    NAKAMURA, T
    ZENTRALBLATT FUR CHIRURGIE, 1988, 113 (20): : 1329 - 1337
  • [2] Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [3] Biochemical Outcomes for Patients With Intermediate-Risk Prostate Cancer Treated With Proton Therapy
    Bryant, C. M.
    Mendenhall, W. M.
    Hoppe, B. S.
    Henderson, R. H.
    Nichols, R. C., Jr.
    Su, Z.
    Williams, C. R.
    Morris, C. G.
    Li, Z.
    Mendenhall, N. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E242 - E243
  • [4] Survival of Low-Risk and Intermediate-Risk Prostate Cancer Patients Treated with IMRT Or Brachytherapy
    Podder, T.
    Dey, A.
    Datta, S.
    Biswas, T.
    MEDICAL PHYSICS, 2020, 47 (06) : E318 - E318
  • [5] Survival outcomes of low-risk and intermediate-risk stage IB1 cervical cancer patients
    Vanichtantikul, Asama
    Tantbirojn, Patou
    Manchana, Tarinee
    ASIAN BIOMEDICINE, 2019, 13 (01) : 27 - 32
  • [6] Contemporary Real-World Outcomes of Surgical Aortic Valve Replacement in 141,905 Low-Risk, Intermediate-Risk, and High-Risk Patients
    Thourani, Vinod H.
    Suri, Rakesh M.
    Gunter, Rebecca L.
    Sheng, Shubin
    O'Brien, Sean M.
    Ailawadi, Gorav
    Szeto, Wilson Y.
    Dewey, Todd M.
    Guyton, Robert A.
    Bavaria, Joseph E.
    Babaliaros, Vasilis
    Gammie, James S.
    Svensson, Lars
    Williams, Mathew
    Badhwar, Vinay
    Mack, Michael J.
    ANNALS OF THORACIC SURGERY, 2015, 99 (01): : 55 - 61
  • [7] Intermediate-Risk Group in Patients with Transitional Cell Carcinoma of the Bladder: Prediction of High-Risk Patients in This Heterogeneous Group
    Yencilek, F.
    Onal, B.
    Erozenci, A.
    Talat, Z.
    Ataus, S.
    UROLOGIA INTERNATIONALIS, 2009, 83 (03) : 295 - 299
  • [8] Why low risk class CURB patients with CAP are hospitalized?
    Liapikou, Adamantia
    Melachrinidou, Myrsini
    Theodorakopoulou, Elpida
    Spiliotopoulou, Andromaxi
    Anastasopoulos, Andreas
    Koutsoukou, Antonia
    Koulouris, Nikolaos
    Demertzis, Panos
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [9] Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database
    Agrawal, Rishabh
    Dey, Asoke
    Datta, Sujay
    Nassar, Ana
    Grubb, William
    Traughber, Bryan
    Biswas, Tithi
    Ove, Roger
    Podder, Tarun
    CANCERS, 2022, 14 (22)
  • [10] Impact of preoperative leukocyte alteration in surgically-treated early-stage cervical cancer patients with low-risk, intermediate-risk or high-risk factors
    Matsumoto, Y.
    Mabuchi, S.
    Kozasa, K.
    Kuroda, H.
    Sasano, T.
    Yokoi, E.
    Sawada, K.
    Kimura, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 939 - 946
12345